Creo Medical Group PLC (LON:CREO – Get Free Report)’s share price was up 3.9% during trading on Monday . The company traded as high as GBX 33.98 ($0.43) and last traded at GBX 33.50 ($0.42). Approximately 383,502 shares were traded during mid-day trading, a decline of 44% from the average daily volume of 687,521 shares. The stock had previously closed at GBX 32.25 ($0.41).
Creo Medical Group Trading Down 0.4 %
The firm has a market capitalization of £120.55 million, a price-to-earnings ratio of -476.43 and a beta of 0.86. The company has a debt-to-equity ratio of 13.88, a quick ratio of 2.19 and a current ratio of 3.83. The company has a 50 day moving average price of GBX 34.94 and a two-hundred day moving average price of GBX 36.70.
About Creo Medical Group
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
See Also
- Five stocks we like better than Creo Medical Group
- Financial Services Stocks Investing
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Quiet Period Expirations Explained
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- The 3 Best Blue-Chip Stocks to Buy Now
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
